Spring 2026
By Hannah White Hannah
A $150,000 grant from the Lung Cancer Research Foundation supports William Feng, PhD, in investigating AP-1 transcription factors as a potential “Achilles’ heel” in KRAS-mutant lung cancer. His research aims to develop a novel AP-1–targeted therapy to overcome drug resistance and improve outcomes for patients with this challenging disease.